UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease

Brain (London, England : 1878), 2016-03, Vol.139 (Pt 3), p.922-936

2016

Link zum Volltext

Verfügbarkeit prüfen

Early astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography

Scientific reports, 2015-11, Vol.5 (1), p.16404-16404, Article 16404

2015

Link zum Volltext

Verfügbarkeit prüfen

Identification and description of three families with familial Alzheimer disease that segregate variants in the SORL1 gene

Acta neuropathologica communications, 2017-06, Vol.5 (1), p.43-43, Article 43

2017

Link zum Volltext

Verfügbarkeit prüfen

Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study

Alzheimer's research & therapy, 2018-05, Vol.10 (1), p.45-45, Article 45

2018

Link zum Volltext

Verfügbarkeit prüfen

Alzheimer disease - A 21st century epidemic

Laeknabladid, 2018, Vol.104 (5), p.229-229

Thordardottir, Steinunn

2018

Link zum Volltext

Verfügbarkeit prüfen

Plasma biomarker profiles in autosomal dominant Alzheimer’s disease

Brain (London, England : 1878), 2023-03, Vol.146 (3), p.1132-1140

2023

Link zum Volltext

Verfügbarkeit prüfen

The power of genetic knowledge of a population: A lesson from the Generation study 2

Alzheimer's & dementia, 2020-12, Vol.16, p.n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

The power of genetic knowledge of a population: A lesson from the Generation study 2: Human/Human trials: Anti‐amyloid

Alzheimer's & dementia, 2020-12, Vol.16 (S9)

2020

Link zum Volltext

Verfügbarkeit prüfen

Findings from the Swedish Study on Familial Alzheimer's Disease Including the APP Swedish Double Mutation

Journal of Alzheimer's disease, 2018-01, Vol.64 (s1), p.S491

2018

Link zum Volltext

Verfügbarkeit prüfen

APOE ε4 influences cognitive decline positively in APP and negatively in PSEN1 mutation carriers with autosomal‐dominant Alzheimer's disease

European journal of neurology, 2022-12, Vol.29 (12), p.3580-3589

2022

Link zum Volltext

Verfügbarkeit prüfen

Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers

Neurology, 2012-07, Vol.79 (3), p.229

2012

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal cognitive decline in autosomal-dominant Alzheimer's disease varies with mutations in APP and PSEN1 genes

Neurobiology of aging, 2019-10, Vol.82, p.40-47

2019

Link zum Volltext

Verfügbarkeit prüfen

Put health care professionals in the lead

Laeknabladid, 2021-06, Vol.107 (o6), p.277-277

Þórðardóttir, Steinunn

2021

Link zum Volltext

Verfügbarkeit prüfen

Biomarkers in Preclinical Familial Alzheimer Disease

Thordardottir, Steinunn

2018

Link zum Volltext
ProQuest

Predicting Cognitive Decline across Four Decades in Mutation Carriers and Non-carriers in Autosomal-Dominant Alzheimer’s Disease

Journal of the International Neuropsychological Society, 2017-03, Vol.23 (3), p.195-203

2017

Link zum Volltext

Verfügbarkeit prüfen

Preclinical cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers in Swedish familial Alzheimer's disease

Journal of Alzheimer's disease, 2015-01, Vol.43 (4), p.1393

2015

Link zum Volltext

Verfügbarkeit prüfen

GENOTYPE-DEPENDENT LONGITUDINAL TRAJECTORIES OF COGNITIVE DECLINE IN AUTOSOMAL DOMINANT ALZHEIMER’S DISEASE

Alzheimer's & dementia, 2017-07, Vol.13 (7), p.P1554-P1554

2017

Link zum Volltext

Verfügbarkeit prüfen

The effects of different familial Alzheimer's disease mutations on APP processing in vivo

Alzheimer's research & therapy, 2017-02, Vol.9 (1), p.9-9, Article 9

2017

Link zum Volltext

Verfügbarkeit prüfen

Alzheimer-sjúkdómur faraldur 21. aldarinnar

Laeknabladid, 2018-05, Vol.2018 (5), p.229-229

Þórðardóttir, Steinunn

2018

Link zum Volltext

Verfügbarkeit prüfen

The Effects of Gene Mutations on Default Mode Network in Familial Alzheimer's Disease

Journal of Alzheimer's disease, 2017-01, Vol.56 (1), p.327

2017

Link zum Volltext

Verfügbarkeit prüfen

IC‐P‐126: Divergent pattern of changes in astrocytosis and fibrillar amyloid plaques as measured by PET in autosomal‐dominant and sporadic Alzheimer's disease

Alzheimer's & dementia, 2015-07, Vol.11 (7S_Part_2), p.P86-P86

2015

Link zum Volltext

Verfügbarkeit prüfen

O1‐02‐03: Divergent pattern of changes in astrocytosis and fibrillar amyloid plaques as measured by PET in autosomal‐dominant and sporadic Alzheimer's disease

Alzheimer's & dementia, 2015-07, Vol.11 (7S_Part_3), p.P127-P127

2015

Link zum Volltext

Verfügbarkeit prüfen

The effects of gene mutations on the cerebrospinal fluid levels of soluble amyloid precursor proteins in familial Alzheimer's disease

Alzheimer's & dementia, 2013-07, Vol.9 (4), p.P226-P227

2013

Link zum Volltext

Verfügbarkeit prüfen

P1–203: The effects of gene mutations on the cerebrospinal fluid levels of soluble amyloid precursor proteins in familial Alzheimer's disease

Alzheimer's & dementia, 2013-07, Vol.9 (4S_Part_6), p.P226-P227

2013

Link zum Volltext

Verfügbarkeit prüfen

Novel progranulin mutations with reduced serum-progranulin levels in frontotemporal lobar degeneration

European journal of human genetics : EJHG, 2013-11, Vol.21 (11), p.1260-1265

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(31)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease

Early astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography

Identification and description of three families with familial Alzheimer disease that segregate variants in the SORL1 gene

Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study

Alzheimer disease - A 21st century epidemic

Plasma biomarker profiles in autosomal dominant Alzheimer’s disease

The power of genetic knowledge of a population: A lesson from the Generation study 2

The power of genetic knowledge of a population: A lesson from the Generation study 2: Human/Human trials: Anti‐amyloid

Findings from the Swedish Study on Familial Alzheimer's Disease Including the APP Swedish Double Mutation

APOE ε4 influences cognitive decline positively in APP and negatively in PSEN1 mutation carriers with autosomal‐dominant Alzheimer's disease

Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers

Longitudinal cognitive decline in autosomal-dominant Alzheimer's disease varies with mutations in APP and PSEN1 genes

Put health care professionals in the lead

Biomarkers in Preclinical Familial Alzheimer Disease

Predicting Cognitive Decline across Four Decades in Mutation Carriers and Non-carriers in Autosomal-Dominant Alzheimer’s Disease

Preclinical cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers in Swedish familial Alzheimer's disease

GENOTYPE-DEPENDENT LONGITUDINAL TRAJECTORIES OF COGNITIVE DECLINE IN AUTOSOMAL DOMINANT ALZHEIMER’S DISEASE

The effects of different familial Alzheimer's disease mutations on APP processing in vivo

Alzheimer-sjúkdómur faraldur 21. aldarinnar

The Effects of Gene Mutations on Default Mode Network in Familial Alzheimer's Disease

IC‐P‐126: Divergent pattern of changes in astrocytosis and fibrillar amyloid plaques as measured by PET in autosomal‐dominant and sporadic Alzheimer's disease

O1‐02‐03: Divergent pattern of changes in astrocytosis and fibrillar amyloid plaques as measured by PET in autosomal‐dominant and sporadic Alzheimer's disease

The effects of gene mutations on the cerebrospinal fluid levels of soluble amyloid precursor proteins in familial Alzheimer's disease

P1–203: The effects of gene mutations on the cerebrospinal fluid levels of soluble amyloid precursor proteins in familial Alzheimer's disease

Novel progranulin mutations with reduced serum-progranulin levels in frontotemporal lobar degeneration

Suchergebnisse filtern